Active Clinical Trials at OOS

All Clinical Trials

BDX-00146 (BIODESIX)

Tumor site:
Lung
Description:
An Observational Study Assessing the Clinical Effectiveness of the VeriStrat® Test and Validating Immunotherapy Tests in Subjects with Non-Small Cell Lung Cancer (INSIGHT)
Available at:

Get Fit Prostate (Through OHSU)

Tumor site:
Prostate
Description:
A Comparison Study of distinct exercise programs of tai ji quan (also known as “tai chi”) vs strength training, to prevent falls and frailty in prostate cancer survivors who have received ADT.
Available at:
Salem Cancer Institute (at Salem Hospital) as a site for Oregon Health Sciences University (OHSU)
Notes:
Oregon Oncology Specialists is currently enrolling patients in the Get Fit Prostate Study, which is being run by Oregon Health Science University (OHSU). Salem Cancer Institute at Salem Hospital is a Get Fit site.

BeSpoke 20-041-NCP (BESPOKE)

Tumor site:
Colorectal
Description:
An Observational Study of ctDNA Guided Therapy in Colorectal Cancer.
Available at:

Mirati KRYSTAL 7 (Mirati 849-007)

Tumor site:
Lung (NSCLC)
Description:
Phase 2 Trial of MRTX849 Plus Pembrolizumab for NSCLC With KRAS G12C Mutation (KRYSTAL-7)
Available at:
Notes:
NCT: 04613596

Mirati KRYSTAL 12 (Mirati 849-012)

Tumor site:
Lung (NSCLC)
Description:
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-12)
Available at:
Notes:
NCT: 04685135

Prevalence (64091742PCR0002)

Tumor site:
Prostate
Description:
Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer. Observational study.
Available at:
Page 1 of
Page: